These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 27590431)

  • 1. Evaluation of vaccination safety in children with mastocytosis.
    Parente R; Pucino V; Magliacane D; Petraroli A; Loffredo S; Marone G; Triggiani M
    Pediatr Allergy Immunol; 2017 Feb; 28(1):93-95. PubMed ID: 27590431
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccination of children – summary and conclusions from a systematic review.
    Silfverdal SA; Nilsson L; Blennow M; Carlsson RM; Hanson LÅ; Lindberg A; Lindquist L; Magnusson M; Norlund A; Nyrén O; Olcén P; Olin P; Säwe J; Söderström A; Trollfors B; Örtqvist Å
    Acta Paediatr; 2010 Sep; 99(9):1287-9. PubMed ID: 20937069
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccine safety in an era of novel vaccines: a proposed research agenda.
    Poland GA; Kennedy RB
    Nat Rev Immunol; 2022 Apr; 22(4):203-204. PubMed ID: 35197577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cells in breast cancer.
    Aaltomaa S; Lipponen P; Papinaho S; Kosma VM
    Anticancer Res; 1993; 13(3):785-8. PubMed ID: 8317912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Reactive Oxygen Species and the Antioxidant Protein DJ-1 in Mastocytosis.
    Kim DK; Beaven MA; Kulinski JM; Desai A; Bandara G; Bai Y; Prussin C; Schwartz LB; Komarow H; Metcalfe DD; Olivera A
    PLoS One; 2016; 11(9):e0162831. PubMed ID: 27611333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination management in children and adults with mastocytosis.
    Zanoni G; Zanotti R; Schena D; Sabbadini C; Opri R; Bonadonna P
    Clin Exp Allergy; 2017 Apr; 47(4):593-596. PubMed ID: 28079293
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: A Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & Immunology.
    Carter MC; Metcalfe DD; Matito A; Escribano L; Butterfield JH; Schwartz LB; Bonadonna P; Zanotti R; Triggiani M; Castells M; Brockow K
    J Allergy Clin Immunol; 2019 Mar; 143(3):880-893. PubMed ID: 30528617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing vaccination reactions in pediatric patients with maculopapular cutaneous mastocytosis.
    Johansen ML; Lawley LP
    Pediatr Dermatol; 2021 Mar; 38(2):502-503. PubMed ID: 33393144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.
    Rama TA; Moreira A; Castells M
    J Allergy Clin Immunol; 2021 Mar; 147(3):877-878. PubMed ID: 33485650
    [No Abstract]   [Full Text] [Related]  

  • 10. Challenges in Drug and Hymenoptera Venom Hypersensitivity Diagnosis and Management in Mastocytosis.
    Giannetti MP; Nicoloro-SantaBarbara J; Godwin G; Middlesworth J; Espeland A; Douvas JL; Castells MC
    Diagnostics (Basel); 2024 Jan; 14(2):. PubMed ID: 38247999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 Vaccination Is Safe among Mast Cell Disorder Patients, under Adequate Premedication.
    Rama TA; Miranda J; Silva D; Amaral L; Castro E; Coimbra A; Moreira A; Plácido JL
    Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous mastocytosis in childhood.
    Nemat K; Abraham S
    Allergol Select; 2022; 6():1-10. PubMed ID: 35028497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report and Review of the Literature: Bullous Skin Eruption After the Booster-Dose of Influenza Vaccine in a Pediatric Patient With Polymorphic Maculopapular Cutaneous Mastocytosis.
    Sarcina D; Giovannini M; Oranges T; Barni S; Pedaci FA; Liccioli G; Canessa C; Sarti L; Lodi L; Filippeschi C; Azzari C; Ricci S; Mori F
    Front Immunol; 2021; 12():688364. PubMed ID: 34335590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Not Available].
    Klimek L; Bergmann KC; Brehler R; Pfützner W; Worm M; Hartmann K; Jakob T; Novak N; Ring J; Hamelmann E; Ankermann T; Schmidt SM; Untersmayr E; Hötzenecker W; Jensen-Jarolim E; Zuberbier T
    Allergo J; 2021; 30(3):22-43. PubMed ID: 33967401
    [No Abstract]   [Full Text] [Related]  

  • 15. Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI.
    Klimek L; Bergmann KC; Brehler R; Pfützner W; Zuberbier T; Hartmann K; Jakob T; Novak N; Ring J; Merk H; Hamelmann E; Ankermann T; Schmidt S; Untersmayr E; Hötzenecker W; Jensen-Jarolim E; Brockow K; Mahler V; Worm M
    Allergo J Int; 2021; 30(3):79-95. PubMed ID: 33898162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM).
    Bonadonna P; Brockow K; Niedoszytko M; Elberink HO; Akin C; Nedoszytko B; Butterfield JH; Alvarez-Twose I; Sotlar K; Schwaab J; Jawhar M; Castells M; Sperr WR; Hermine O; Gotlib J; Zanotti R; Reiter A; Broesby-Olsen S; Bindslev-Jensen C; Schwartz LB; Horny HP; Radia D; Triggiani M; Sabato V; Carter MC; Siebenhaar F; Orfao A; Grattan C; Metcalfe DD; Arock M; Gulen T; Hartmann K; Valent P
    J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2139-2144. PubMed ID: 33831618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021.
    Lange M; Hartmann K; Carter MC; Siebenhaar F; Alvarez-Twose I; Torrado I; Brockow K; Renke J; Irga-Jaworska N; Plata-Nazar K; Ługowska-Umer H; Czarny J; Belloni Fortina A; Caroppo F; Nowicki RJ; Nedoszytko B; Niedoszytko M; Valent P
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33806685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis.
    Brockow K; Plata-Nazar K; Lange M; Nedoszytko B; Niedoszytko M; Valent P
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33799959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast Cell Activation Disorders.
    Giannetti A; Filice E; Caffarelli C; Ricci G; Pession A
    Medicina (Kaunas); 2021 Jan; 57(2):. PubMed ID: 33573161
    [No Abstract]   [Full Text] [Related]  

  • 20. Pediatric Mastocytosis: Recognition and Management.
    Schaffer JV
    Am J Clin Dermatol; 2021 Mar; 22(2):205-220. PubMed ID: 33492611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.